Scott Boiko
Impact in
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
- Aging top 5%
- Genetics, Aging, and Longevity in Model Organisms
Papers in
- Oncology 8
- Cancer-related Molecular Pathways 5
- CAR-T cell therapy research 2
-
- Ubiquitin and proteasome pathways 2
- Protein Degradation and Inhibitors 2
- RNA modifications and cancer 2
- Co-authors
- Serena Dato (1 shared paper)Cristiana Barbi (1 shared paper)Qihua Tan (1 shared paper)Vincenzo Mari (1 shared paper)Valentina Greco (1 shared paper)Giuseppe Passarino (1 shared paper)A.I. Yashin (1 shared paper)Claudio Franceschi (1 shared paper)
- Journals
- Cancer Research (6 papers)Journal of Clinical Oncology (1 paper)Blood (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Experimental Gerontology (1 paper)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
Scott Boiko
12 papers receiving 285 citations
Peers
Comparison fields: 5 of 53
- Geriatrics and Gerontology 158
- Aging 51
- Physiology 127
- Physiology 13
- Epidemiology 73
Countries citing papers authored by Scott Boiko
This map shows the geographic impact of Scott Boiko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Boiko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Boiko more than expected).
Fields of papers citing papers by Scott Boiko
This network shows the impact of papers produced by Scott Boiko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Boiko. The network helps show where Scott Boiko may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Boiko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 237 | |
| 2 | 2020 | 19 | |
| 3 | 2018 | 10 | |
| 4 | 2024 | 8 | |
| 5 | 2018 | 4 | |
| 6 | 2016 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2020 | 3 | |
| 9 | 2025 | 2 | |
| 10 | 2025 | 2 | |
| 11 | 2023 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2019 | 1 |
About Scott Boiko
Scott Boiko is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Genetics and Biotechnology, having authored 13 papers that have together received 294 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Ubiquitin and proteasome pathways (2 papers), Protein Degradation and Inhibitors (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Cancer Research and Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), RNA modifications and cancer (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Geriatrics and Gerontology (158 citations), Aging (51 citations), Physiology (127 citations), Physiology (13 citations) and Epidemiology (73 citations). Scott Boiko has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Serena Dato, Cristiana Barbi, Qihua Tan, Vincenzo Mari, Valentina Greco, Giuseppe Passarino, A.I. Yashin, Claudio Franceschi, Giuseppina Rose and G. De Benedictis. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Blood, Bioorganic & Medicinal Chemistry Letters and Experimental Gerontology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.